Back to Investors

REVA

Evidence PackPROIndependent
Real Estate
AUM
$20M
Ownership
independent
Stakeability
27 / VERY LOW
Priority
Tier
Employees
2

REVA focuses on Real Estate investments in North America.

SEC RegisteredFund PerformanceBDC ExposureTeam DataRegulatoryLegal FilingsNews Coverage

Coverage

58%

Adaptive profile: standard

Signals present
7/12
SEC / ADVFund Performance(5)BDC Exposure(3)13F Holders(0)Team(16)ILS Deals(0)Regulatory(15)Legal(1)Lobbying(0)Hiring(0)News(10)GP Stakes Deals(0)

Data Freshness

Recent Changes

Stakeability Breakdown

27 / 100
Fund PerformanceAUM growth and fundraising track record
17
Team StabilityLeadership continuity and key person risk
10
Market PositionBrand strength and competitive positioning
27
Succession ReadinessNext-gen leadership and governance structure
60
Transaction FeasibilityLikelihood of a stake transaction
19
Unable to load signal breakdown.

IC Risk Memo

PRO

Investment committee-ready memo with risk analysis and recommendation

Click "Generate Memo" to create an IC-ready analysis

Includes risk factors, citations, and recommendation

CRD Number
311895
SEC File Number
801-120392
Registration Type
Registered
Filing Date
Mar 26, 2025
Employee Count
N/A
Discretionary AUM
$517.3M
Private Funds
1
PE Funds
N/A
VC Funds
N/A
RE Funds
N/A
Hedge Funds
1
Gross Assets (Private)
$517.3M
Source: SEC IAPD

Fund performance data requires Professional

Upgrade your plan to access this section.

Upgrade

BDC exposure data requires Professional

Upgrade your plan to access this section.

Upgrade

Team data requires Professional

Upgrade your plan to access this section.

Upgrade

Team intelligence requires Professional

Upgrade your plan to access this section.

Upgrade

Competition mapping requires Professional

Upgrade your plan to access this section.

Upgrade

Regulatory data requires Professional

Upgrade your plan to access this section.

Upgrade

Legal filings require Professional

Upgrade your plan to access this section.

Upgrade

No GP stakes deals recorded

This GP has not sold a minority stake, making it a potential target.